17:42:37 EST Sat 23 Feb 2019
Enter Symbol
or Name

Login ID:
U S Securities and Exchange Commission
Symbol U : *SEC
Recent Sedar Documents

SEC defendant Panther denies any Biozoom wrongdoing

2018-08-07 10:21 ET - Street Wire

Also Street Wire (U-BIZM) Biozoom Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

James Panther, one of those charged alongside Vancouver's Faiyaz Dean for the pump-and-dump of Biozoom Inc., denies that he did anything wrong. The U.S. Securities and Exchange Commission claims that Mr. Panther was part of a $34-million scheme to sell improperly issued Biozoom shares. (All figures are in U.S. dollars.) Among other things, he helped with manipulative trades and helped organize a paid promotional campaign, the SEC says.

The denials from Mr. Panther are contained in an answer filed on Monday, Aug. 6, in New York. The document is 17 pages long, but consists mostly of generic statements. Mr. Panther does admit to some routine things, such as being a 45-year-old resident of Carlsbad, Calif., but in response to most of the charges against him he simply says that he does not have "knowledge or information" about the specific allegation and denies that he did anything wrong. He asks for a trial by jury.

Mr. Panther is one of four individuals that the SEC charged on May 15, 2018, for Biozoom. In a civil complaint filed in the Southern District of New York, the SEC named him along with Mr. Dean, a Vancouver-Seattle lawyer. The SEC claimed that the group ran a 2013 campaign that boosted Biozoom, a purported skin health company, to a $4.50 high on the OTC Bulletin Board. The SEC said that the group sold 14 million shares from nominee accounts before the regulator ended the scheme by halting the stock.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2019 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.